rs851007

Variant summary

Our verdict is Benign. The variant received -12 ACMG points: 0P and 12B. BP4_StrongBA1

The ENST00000491957.5(MAPK14):​n.*460G>A variant causes a non coding transcript exon change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.472 in 514,934 control chromosomes in the GnomAD database, including 61,743 homozygotes. In-silico tool predicts a benign outcome for this variant. No clinical diagnostic laboratories have submitted clinical-significance assessments for this variant to ClinVar.

Frequency

Genomes: 𝑓 0.42 ( 15016 hom., cov: 32)
Exomes 𝑓: 0.49 ( 46727 hom. )

Consequence

MAPK14
ENST00000491957.5 non_coding_transcript_exon

Scores

2

Clinical Significance

Not reported in ClinVar

Conservation

PhyloP100: -0.00200

Publications

9 publications found
Variant links:
Genes affected
MAPK14 (HGNC:6876): (mitogen-activated protein kinase 14) The protein encoded by this gene is a member of the MAP kinase family. MAP kinases act as an integration point for multiple biochemical signals, and are involved in a wide variety of cellular processes such as proliferation, differentiation, transcription regulation and development. This kinase is activated by various environmental stresses and proinflammatory cytokines. The activation requires its phosphorylation by MAP kinase kinases (MKKs), or its autophosphorylation triggered by the interaction of MAP3K7IP1/TAB1 protein with this kinase. The substrates of this kinase include transcription regulator ATF2, MEF2C, and MAX, cell cycle regulator CDC25B, and tumor suppressor p53, which suggest the roles of this kinase in stress related transcription and cell cycle regulation, as well as in genotoxic stress response. Four alternatively spliced transcript variants of this gene encoding distinct isoforms have been reported. [provided by RefSeq, Jul 2008]

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -12 ACMG points.

BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.8).
BA1
GnomAd4 highest subpopulation (SAS) allele frequency at 95% confidence interval = 0.601 is higher than 0.05.

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect Exon rank MANE Protein UniProt
MAPK14NM_139012.3 linkc.762+193G>A intron_variant Intron 9 of 11 ENST00000229794.9 NP_620581.1 Q16539-1A0A024RD15

Ensembl

Gene Transcript HGVSc HGVSp Effect Exon rank TSL MANE Protein Appris UniProt
MAPK14ENST00000229794.9 linkc.762+193G>A intron_variant Intron 9 of 11 1 NM_139012.3 ENSP00000229794.4 Q16539-1

Frequencies

GnomAD3 genomes
AF:
0.420
AC:
63868
AN:
151952
Hom.:
15024
Cov.:
32
show subpopulations
Gnomad AFR
AF:
0.201
Gnomad AMI
AF:
0.470
Gnomad AMR
AF:
0.449
Gnomad ASJ
AF:
0.448
Gnomad EAS
AF:
0.258
Gnomad SAS
AF:
0.620
Gnomad FIN
AF:
0.464
Gnomad MID
AF:
0.557
Gnomad NFE
AF:
0.536
Gnomad OTH
AF:
0.423
GnomAD4 exome
AF:
0.494
AC:
179336
AN:
362864
Hom.:
46727
Cov.:
3
AF XY:
0.504
AC XY:
95964
AN XY:
190454
show subpopulations
African (AFR)
AF:
0.198
AC:
2083
AN:
10542
American (AMR)
AF:
0.418
AC:
4993
AN:
11936
Ashkenazi Jewish (ASJ)
AF:
0.459
AC:
5354
AN:
11654
East Asian (EAS)
AF:
0.249
AC:
6793
AN:
27250
South Asian (SAS)
AF:
0.612
AC:
17698
AN:
28910
European-Finnish (FIN)
AF:
0.452
AC:
12248
AN:
27082
Middle Eastern (MID)
AF:
0.564
AC:
1239
AN:
2196
European-Non Finnish (NFE)
AF:
0.535
AC:
118414
AN:
221516
Other (OTH)
AF:
0.483
AC:
10514
AN:
21778
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.500
Heterozygous variant carriers
0
4026
8052
12078
16104
20130
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Exome Hom
Variant carriers
0
524
1048
1572
2096
2620
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.420
AC:
63854
AN:
152070
Hom.:
15016
Cov.:
32
AF XY:
0.420
AC XY:
31227
AN XY:
74358
show subpopulations
African (AFR)
AF:
0.201
AC:
8342
AN:
41492
American (AMR)
AF:
0.448
AC:
6850
AN:
15286
Ashkenazi Jewish (ASJ)
AF:
0.448
AC:
1554
AN:
3470
East Asian (EAS)
AF:
0.259
AC:
1338
AN:
5158
South Asian (SAS)
AF:
0.619
AC:
2987
AN:
4822
European-Finnish (FIN)
AF:
0.464
AC:
4913
AN:
10586
Middle Eastern (MID)
AF:
0.548
AC:
161
AN:
294
European-Non Finnish (NFE)
AF:
0.536
AC:
36395
AN:
67940
Other (OTH)
AF:
0.419
AC:
885
AN:
2110
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.499
Heterozygous variant carriers
0
1754
3509
5263
7018
8772
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Genome Hom
Variant carriers
0
608
1216
1824
2432
3040
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.333
Hom.:
950
Bravo
AF:
0.401
Asia WGS
AF:
0.395
AC:
1372
AN:
3478

ClinVar

Not reported in ClinVar

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
-0.80
CADD
Benign
7.6
DANN
Benign
0.74
PhyloP100
-0.0020
RBP_binding_hub_radar
0.0
RBP_regulation_power_radar
2.2
Mutation Taster
=100/0
polymorphism (auto)

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs851007; hg19: chr6-36064036; API